Clinical trial: The Effect of an Exercise Intervention on Serum Neurofilament Light Chain and Brain Volumetry in Patients With Multiple Sclerosis: A Randomized Controlled Trial

https://clinicaltrials.gov/study/NCT07520812?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20397

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Prospective Observational Multi Cohort Study of Intranasal MuSE Cell Derived Exosomes, MuSE Stem Cells, and Combination Therapy Delivered Via the Kurve Therapeutics ViaNase Device in Patients Receiving International Regenerative Treatments

https://clinicaltrials.gov/study/NCT07521384?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20398

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Danish non-inferiority study of ocrelizumab and rituximab in MS: A randomized study comparing the efficacy of ocrelizumab
and rituximab in active multiple sclerosis

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-514287-84-00?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20405

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Search for clinical trials - EMA

Facing recurrent Glioblastoma (GBM)? In 2026, new multi-target CAR-T clinical trials are offering alternative evaluation pathways. As a professional medical concierge provider, MedBridgeNZ helps patients safely navigate Medical Tourism China.

Read our guide: https://zurl.co/NoHms

#Glioblastoma #CARTtherapy #NeuroOncology #ClinicalTrials #MedicalConcierge #MedBridgeNZ #MedicalTourismChina #ChinaMedicalTourism

Accessing CAR-T Therapy for Glioblastoma in China (2026)

Key Takeaways • Between 2022 and 2025, over 66 CAR-T clinical trials targeting glioblastoma were launched across top medical institutions in China. • Chinese clinical trials utilize multi-antigen targeting (dual or tri-specific CAR-T cells) to address tumor antigen escape. • Advanced manufacturing platforms, such as FasTCAR, have compressed cell production times from several weeks to 24-36 hours. • The estimated cost for experimental CAR-T therapy in Chinese investigator-initiated trials (IITs)

Medbridge Nz

Clinical trial: The HIt HArd and hiT Early in Multiple Sclerosis Trial - HiHat Trial A Phase 2 Study of Sequential Treatment With Rituximab and Cladribine for Relapsing-remitting Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07517185?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20390

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: A randomized, Phase 3, open-label study to investigate pharmacokinetics, safety, and efficacy of subcutaneous compared to intravenous frexalimab in adult participants with multiple sclerosis.

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-519304-28-00?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20396

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Search for clinical trials - EMA

Clinical trial: Home-based Assessment of Medication Understanding and Use in People With Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07518381?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20391

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Efficacy of Extracorporeal Shock Wave Therapy in Enhancing Plantar Sensitivity and Postural Stability in Multiple Sclerosis: A Quantitative Gait and Sensory Analysis

https://clinicaltrials.gov/study/NCT07514104?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20382

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Prospective Cohort Study of Clinical and Biological Data in Patients With Autoimmune Diseases (Immun4Cure Cohort)

https://clinicaltrials.gov/study/NCT07515638?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20383

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Treating previously untreatable cancers: How CAR‑T cell therapy could be made accessible to more patients | The-14

CAR-T therapy offers hope for untreatable cancers, but high costs limit access. Canadian research aims to lower prices and expand treatment nationwide.

The-14 Pictures